EUVIMEDEUVIMED entdecken
Crossref

Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant staphylococcus aureus infection

Xiao-Shan Zhang, Ye-Li Chen, Yu-Zhen Wang, Chuang Chen, Yao-Jie Chen, Fang-Min Xu, Ying Dai, Da-Wei Shi iD, Guan-Yang Lin, Xu-Ben Yu iD, Dan-Zhu Xiang, Chun-Hong Zhang

British Journal of Clinical Pharmacology · 2024

DOI: 10.1111/bcp.15912 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Xiao-Shan Zhang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science and Technology Plan Project of Wenzhou Municipality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aims to establish a population pharmacokinetic (PK) model of teicoplanin in Chinese adult patients to evaluate the dosing regimen in the label sheet and optimize it.

Methods

Nonlinear mixed‐effects modelling was used to estimate PK parameters. Monte Carlo simulations were used to evaluate the attainment of various dosing regimens in achieving the target trough concentrations in patients with normal or decreased renal function.

Results

A total of 115 patients were enrolled in this retrospective study. Creatinine clearance (CrCL) and albumin (ALB) were identified as covariates on the clearance of teicoplanin. For the treatment of non‐complicated methicillin‐resistant Staphylococcus aureus ( MRSA) infections in patients with normal renal function and serum ALB concentration, the recommended dosing regimen was 600 mg q12h with five administrations as the loading dose followed by 600 mg qd as the maintenance dose; for the treatment of serious and/or complicated MRSA infections, the recommended dosing regimen was 800 mg q12h with five administrations as the loading dose followed by 800 mg qd as the maintenance dose. It is worth noting that both the loading and maintenance doses ought to be modified based on the patient's renal function and serum ALB concentration. In addition, trough concentrations of teicoplanin were significantly increased every other week.

Conclusions

Both loading dosing and maintenance dosing regimens were recommended to be adjusted according to patient's renal function and serum ALB concentration. In addition, it is necessary to perform follow‐up therapeutic drug monitoring of teicoplanin at least once every week.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAdultHumansTeicoplaninAnti-Bacterial AgentsRetrospective StudiesDrug MonitoringSerum Albumin

Stichwörter der Autor:innen

dosing optimizationloading dosepopulation pharmacokineticsteicoplanintherapeutic drug monitoring

Substanzen

TeicoplaninAnti-Bacterial AgentsSerum Albumin

Autor:innen und Institutionen

  • Department of Pharmacy, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
  • School of Pharmacy, Wenzhou Medical University, Wenzhou, China.
  • Department of Pharmacy, Dongyang People's Hospital, Jinhua, China.
  • Department of Pharmacy, First Affiliated Hospital of Xiamen University, Xiamen, China.

ORCID-Profile: Da-Wei Shi, Xu-Ben Yu

Förderung

  • National Natural Science Foundation of China
  • Science and Technology Plan Project of Wenzhou Municipality

Zitieren

APA

Zhang, X. S., Chen, Y. L., Wang, Y. Z., Chen, C., Chen, Y. J., Xu, F. M., Dai, Y., Shi, D. W., Lin, G. Y., Yu, X. B., Xiang, D. Z., & Zhang, C. H. (2024). Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant staphylococcus aureus infection. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.15912

Vancouver

Zhang XS, Chen YL, Wang YZ, Chen C, Chen YJ, Xu FM, et al. Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant staphylococcus aureus infection. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.15912

BibTeX
@article{Zhang2024,
  author = {Zhang, Xiao-Shan and Chen, Ye-Li and Wang, Yu-Zhen and Chen, Chuang and Chen, Yao-Jie and Xu, Fang-Min and Dai, Ying and Shi, Da-Wei and Lin, Guan-Yang and Yu, Xu-Ben and Xiang, Dan-Zhu and Zhang, Chun-Hong},
  title = {Model‐based dosing optimization and therapeutic drug monitoring practices of teicoplanin in patients with complicated or non‐complicated methicillin‐resistant staphylococcus aureus infection},
  journal = {British Journal of Clinical Pharmacology},
  year = {2024},
  doi = {10.1111/bcp.15912}
}
Kostenlos starten →